NMR‐based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T₁AM treatment

Abstract

CRDS in combination with NMR and (13) C-metabolic tracing constitute a powerful method of investigation in obesity studies for identifying in vivo biochemical pathway shifts and unanticipated debilitating side effects.